Auto-immune Contribution in Symptom-based Sensory and Autonomic Disorders

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2030

Conditions
Postural Orthostatic Tachycardia Syndrome (POTS)Fibromyalgia (FM)
Interventions
OTHER

Questionnaire and Physical Exam

Standardised participant questionnaires assessing neurological symptoms, including pain (NPSI, DN4, BPI), fatigue (Fatigue Severity Scale), depression and anxiety (PHQ9 and GAD7) and autonomic dysfunction (Malmo PoTS Score and COMPASS-31).

DIAGNOSTIC_TEST

Nerve conduction studies

Measures how fast an electrical impulse moves through sensory and motor nerves. The test will be used to identify/rule out large fibre peripheral neuropathy.

DIAGNOSTIC_TEST

Microneurography

Electrophysiological technique that can record action potentials from individual peripheral nerve axons in humans. The test will be used to identify/rule out small nerve fibre dysfunction.

DIAGNOSTIC_TEST

Quantitative Sensory Testing

Measures psychophysical sensory perception in response to different types of stimuli, such as thermal, mechanical, pressure and vibration. The test will be used to identify/rule out nerve fibre dysfunction, by generating a quantitative sensory profile of different sensory modalities.

DIAGNOSTIC_TEST

Skin biopsy

Safe and minimally invasive procedure to quantify intraepidermal nerve fibres density (IENFD). Reduced IENF density is associated with small fibre neuropathy.

BIOLOGICAL

Blood Product

A blood sample of a maximum of 120ml will be collected from a superficial upper limb vein. Blood aliquots (50ml tubes) will then be centrifuged to separate serum from the peripheral blood cells.

All Listed Sponsors
collaborator

King's College Hospital NHS Trust

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

lead

King's College London

OTHER